Researchers with the James P. Allison Institute™ at The University of Texas MD Anderson Cancer Center have discovered a new ...

Researchers at Moffitt Cancer Center report encouraging early results from a phase 2 study examining whether immunotherapy ...

Immunotherapy for stage 4 prostate cancer is revolutionizing the way advanced disease is being treated, offering hope for patients worldwide. Unlike conventional treatment methods such as surgery and ...

Key Points Interested in Candel Therapeutics, Inc.? Here are five stocks we like better. Candel Therapeutics said it remains ...

Bria-PROS+ is BriaCell’s next generation personalized off-the-shelf immunotherapy for prostate cancer Immune stimulating components of Bria-PROS+ ...

Delivery of a new nanoparticle-based immunotherapy to perivascular tumour-associated macrophages (TAMs) in androgen deprivation therapy (ADT)-treated prostate tumours may increase antitumour immunity ...

Black men with advanced prostate cancer have a greater chance of survival after immunotherapy treatment, at least in part, because of ancestral gene variants in immune responses. That connection is ...

New research has shown that immunotherapy can be effective in treating prostate cancer in men who are selected based on the genetic characteristics of their tumors. In a recent study, it was found ...

Add Yahoo as a preferred source to see more of our stories on Google. Researchers at the University of Arizona Health Sciences have uncovered a promising new approach for treating prostate cancer ...

A personalized peptide vaccine slashed prostate-specific antigen levels by as much as 99.6% in some men with advanced prostate cancer, according to a phase II clinical trial conducted at Kurume ...

Learn how the asthma drug montelukast helped restore immune attacks against tumors in several cancer types.

The Parker Institute for Cancer Immunotherapy (PICI) today announced that research and expertise from across its network will ...